New drug can extend survival in gastric cancer

Health - Oct 14
Health

In Germany, around 17,000 people are diagnosed with gastric cancer every year. The disease is one of the leading causes of tumour-related deaths. This is due to late diagnosis and the rapid spread of tumour cells throughout the body. In two international clinical trials, a team of scientists involving the University of Leipzig Medical Center have investigated a drug that can prolong patients' survival. Thanks to the recently published data, zolbetuximab has now been approved as a drug in Europe. Patients with gastric cancer are expected to be able to be treated with it in Germany from the end of this year. The results have been published in the renowned journal The New England Journal of Medicine.

Life Sciences - Oct 14

How a bacterium becomes a permanent resident in a fungus

Life Sciences

Current findings from a Jena-Zurich research project form an important basis for the creation of artificial symbioses with specific properties that could be used for biotechnological applications in the future.

Health - Oct 14

A novel approach to combat fatty liver disease

Health

Blocking the enzyme ACMSD can significantly reduce damage caused by metabolic liver disease according to a study from EPFL.

Career - Oct 11

’Staff shortages call for attention to healthcare workers’

The healthcare sector is heading toward a global shortage of 10 million workers. Research from Tilburg University shows how HR departments can creatively contribute to the battle for healthcare staff, and why they need to go beyond traditional methods. 'Many healthcare organizations are still looking for candidates who meet all the requirements.'

Environment - Oct 11

Nitrogen pollution drives forest plants west

Environment

Climate change not main driver of shift in distribution of European forest plants. The movement of plant species across Europe has mainly been attributed to climate change.

Health - Oct 11

Investigation about a promising therapy to treat myotonic dystrophy type 1

Universitat de València full-time university professor Rubén Artero is leading a research that has identified a promising therapy for treating myotonic dystrophy type 1 (DM1), based on anti-miRs. The study is being carried out by the Human Translational Genomics Group of the INCLIVA-Universitat de València Health Research Institute (Biotecmed). Myotonic dystrophy is a complex genetic disorder caused by an abnormally high number of CTG repeats (a specific type of DNA sequence) in the DMPK gene.

Chemistry - Oct 14

New method for the safe storage of hydrogen

Chemistry

The safe storage of hydrogen continues to pose a technical and scientific challenge. A research team at the Chair of Chemistry of Plastics at the University of Leoben has developed an innovative method for the chemical storage of hydrogen, which could be used in the future, particularly in the field of mobility and in decentralized hydrogen supply.

How did the building blocks of life arrive on Earth?

Astronomy & Space

Researchers have used the chemical fingerprints of zinc contained in meteorites to determine the origin of volatile elements on Earth.

Archaeologists discover Armenia’s oldest church

History & Archeology

Joint discovery by an Armenian-German team in the ancient city of Artaxata. Archaeologists from the National Academy of Sciences of Armenia and the University of Münster have discovered the remains of a previously unknown early Christian church in the ancient city of Artaxata.

Health - Oct 11

Innate immunity envelops bacteria

Health

The protein GBP1 is a vital component of our body's natural defence against pathogens. This substance fights against bacteria and parasites by enveloping them in a protein coat, but how the substance manages to do this has remained unknown until now. Researchers from Delft University of Technology have now unravelled how this protein operates. This new knowledge, published in Nature Structural & Molecular Biology

Environment - Oct 11

International team of researchers unveil key drivers behind natural CO2 jumps on centennial scales

Environment

A new study published in Nature Geoscience by an international team of scientists provides new insights into the natural mechanisms behind century-scale increases in atmospheric carbon dioxide (CO2), known as CO2 jumps.

Selected Job Offers
Pedagogy - 14.10
Associate Professor of Educational Testing University of Luxembourg
Environment - 11.10
Chef/fe de la section nuisances et laboratoire (80-100%) Chef/in der Sektion Umweltbelastung und Labor... Etat du Valais - Service de l’environnement, Sion
Social Sciences - 11.10
Wissenschaftliche*r Mitarbeiter*in (80%) Fachhochschule Nordwestschweiz FHNW, Muttenz
Economics - 10.10
Postdoktorand:in 65 % (m/w/d) Universität Liechtenstein
Agronomy/Food Science - 10.10
PostDoc ’Dairy Housing Emissions when Combined with Grazing’ Agroscope, Ettenhausen
Economics - 10.10
Zwei Researcher (m/w/d) mit Forschungsschwerpunkt „Digitales Zentralbankgeld“ Deutsche Bundesbank, Frankfurt am Main
Materials Science - 09.10
Faculty Position in Surface and lnterface Science & Tribology EPFL, Lausanne
Pedagogy - 04.10
Associate Professor in Cognitive Psychology and Inclusive Education University of Applied Sciences and Arts of Southern Switzerland - SUPSI
Pedagogy - 04.10
Associate Professor in Educational Science University of Applied Sciences and Arts of Southern Switzerland - SUPSI
Education - 03.10
Dozentin / Dozent mit Leitungsfunktion in der Weiterbildung 50 -80% Hochschule Luzern - Wirtschaft
Agronomy/Food Science - 27.09
Technical / scientific Staff - Food and Food Waste LCA Agroscope, Zürich (Expected medium-term place of work: 1725 Posieux)
Agronomy/Food Science - 27.09
Technical / scientific Staff - Nutrition LCA Agroscope, Zürich (Expected medium-term place of work: 1725 Posieux)
Electroengineering - 26.09
Faculty Position in Energy Storage Systems EPFL, Lausanne
Employers of the Week